Fink LM - Search Results

1

Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy.

Poirier LA, Brown AT, Fink LM, Wise CK, Randolph CJ, Delongchamp RR, Fonseca VA. Poirier LA, et al. Among authors: fink lm. Metabolism. 2001 Sep;50(9):1014-8. doi: 10.1053/meta.2001.25655. Metabolism. 2001. PMID: 11555831 Clinical Trial.

2

Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease.

Munshi MN, Stone A, Fink L, Fonseca V. Munshi MN, et al. Metabolism. 1996 Jan;45(1):133-5. doi: 10.1016/s0026-0495(96)90211-5. Metabolism. 1996. PMID: 8544771

3

Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat.

Fonseca V, Dicker-Brown A, Ranganathan S, Song W, Barnard RJ, Fink L, Kern PA. Fonseca V, et al. Metabolism. 2000 Jun;49(6):736-41. doi: 10.1053/meta.2000.6256. Metabolism. 2000. PMID: 10877198

4

The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase: studies in hepatocytes.

Dicker-Brown A, Fonseca VA, Fink LM, Kern PA. Dicker-Brown A, et al. Among authors: fink lm. Atherosclerosis. 2001 Oct;158(2):297-301. doi: 10.1016/s0021-9150(01)00442-7. Atherosclerosis. 2001. PMID: 11583707

5

Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects.

Fonseca VA, Mudaliar S, Schmidt B, Fink LM, Kern PA, Henry RR. Fonseca VA, et al. Among authors: fink lm. Metabolism. 1998 Jun;47(6):686-9. doi: 10.1016/s0026-0495(98)90031-2. Metabolism. 1998. PMID: 9627367

6

Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects.

Fonseca VA, Fink LM, Kern PA. Fonseca VA, et al. Among authors: fink lm. Atherosclerosis. 2003 Mar;167(1):105-9. doi: 10.1016/s0021-9150(02)00386-6. Atherosclerosis. 2003. PMID: 12618274

7

Hyperhomocysteinemia in type 2 diabetes mellitus: cardiovascular risk factors and effect of treatment with folic acid and pyridoxine.

Baliga BS, Reynolds T, Fink LM, Fonseca VA. Baliga BS, et al. Among authors: fink lm. Endocr Pract. 2000 Nov-Dec;6(6):435-41. doi: 10.4158/EP.6.6.435. Endocr Pract. 2000. PMID: 11155214

8

Hyperhomocysteinemia and premature vascular occlusive disease.

Guba SC, Fink LM, Fonseca V. Guba SC, et al. Among authors: fink lm. Am J Med Sci. 1998 Apr;315(4):279-85. doi: 10.1097/00000441-199804000-00011. Am J Med Sci. 1998. PMID: 9537644

9

Hyperhomocysteinemia and microalbuminuria in diabetes.

Fonseca VA, Reynolds T, Fink LM. Fonseca VA, et al. Among authors: fink lm. Diabetes Care. 1998 Jun;21(6):1028. doi: 10.2337/diacare.21.6.1028. Diabetes Care. 1998. PMID: 9614629 No abstract available.

10

Oxidative stress in diabetic macrovascular disease: does homocysteine play a role?

Fonseca VA, Stone A, Munshi M, Baliga BS, Aljada A, Thusu K, Fink L, Dandona P. Fonseca VA, et al. South Med J. 1997 Sep;90(9):903-6. doi: 10.1097/00007611-199709000-00008. South Med J. 1997. PMID: 9305300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters